BackgroundStudents’ perceptions of their learning environment, by defining its strengths and weaknesses, are important for continuous improvement of the educational environments and curriculum. Therefore, the aim of this study was to explore students’ perceptions of their learning environment, among medical students in Malaysia. Various aspects of the education environment were compared between year levels and sex.MethodsThis cross-sectional study was conducted at the Management and Science University, Shah Alam, Malaysia in 2012. A total number of 438 medical students participated in this study, and the response rate was 87.6%. Data were analyzed using SPSS. Comparisons of the mean scores of Dundee Ready Education Environment Measure (DREEM) subscales were calculated. The t-test was used to determine statistically significant differences.ResultsThe majority of the study participants were female, Malay, and from year 3 (68.7%, 65.3%, and 55.7%; respectively). Analysis of each of the 50 items of the DREEM inventory showed that 47 items scored ranged between 2.00 and 3.00, and three items scored below 2.00. These were identified as problem areas in this medical school that are required to be critically addressed. The overall score showed that the medical students’ perceptions were positive. The students’ perception toward educational environment was positive for all five DREEM subscales.ConclusionThe study found that, in general, the perceptions of the participants about the learning environment were positive. Nevertheless, the study also found there is a need for curriculum improvement in this school and identified priority areas for such improvement.
Background: Adverse drug reactions (ADRs) represent a serious health problem. Despite all the benefits of modern medicines, evidence continues to mount that ADRs to them are common,
Objectives: This study was aimed to explore the knowledge and beliefs of patients in Ibb, Yemen, regarding generic medicines and identify factors affecting their use of these medicines. Methods: A mixed qualitative and quantitative study was conducted between Jan 1 and Mar 31, 2017 in Ibb, Yemen. A total of 310 patients participated in this study. The questionnaire used for data collection comprised of two sections. The first section covered participants' demographic information and contained six questions addressing patients' ability to differentiate between generic and brand-name medications. The second section comprises 15 items regarding patients' beliefs about generic medicines, answered using a five-point Likert scale. Additionally, seven patients were interviewed using a semi-structured interview guide to explore further the factors affecting their generic medicine use. Results: Only 17.4% of patients knew the difference between generic and brand-name medicines. Approximately 59 (19%) patients believed that generic medicines' efficacy was the same as that of brand-name medicines, while 42 (13.5%) believed that generic medicines took longer to take effect. The vast majority of patients (252) (81.3%) believed that generic medicines were appropriate for less serious medical conditions. Only 84 patients (27.1%) believed that generic medications were the same as brand-name ones. Furthermore, the majority of patients held negative beliefs about generic medicines. The study also found that the price of medicines, physicians' recommendations, and pharmacy dispensers contributed to patients' use of generic medications. Conclusion: This study found that Yemen patients have insufficient knowledge of and negative beliefs about generic medicines. Special oriented and well-designed programs to educate and improve patients and healthcare professionals' understanding and beliefs about generic medicines are urgently needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.